Thu, August 10, 2023
Wed, August 9, 2023
Tue, August 8, 2023

Jason Butler Maintained (VRDN) at Buy with Decreased Target to $42 on, Aug 9th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-42-on-aug-9th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jason Butler of JMP Securities, Maintained "Viridian Therapeutics, Inc." (VRDN) at Buy with Decreased Target from $44 to $42 on, Aug 9th, 2023.

Jason has made no other calls on VRDN in the last 4 months.



There are 5 other peers that have a rating on VRDN. Out of the 5 peers that are also analyzing VRDN, 0 agree with Jason's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Jason


  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Tuesday, July 11th, 2023
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $45 on, Tuesday, July 11th, 2023
  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $47 on, Tuesday, July 11th, 2023
  • Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $51 on, Wednesday, June 14th, 2023
  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $46 on, Wednesday, June 14th, 2023

Publication Contributing Sources